Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 426-427 [2019-00196]

Download as PDF 426 Federal Register / Vol. 84, No. 18 / Monday, January 28, 2019 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), Subcommittee on Procedures Review (SPR), National Institute for Occupational Safety and Health (NIOSH) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Subcommittee for Procedure Reviews (SPR) of the Advisory Board on Radiation and Worker Health (ABRWH). This meeting is open to the public, but without a public comment period. The public is welcome to submit written comments in advance of the meeting, to the contact person below. Written comments received in advance of the meeting will be included in the official record of the meeting. The public is also welcome to listen to the meeting by joining the audio conference (information below). The audio conference line has 150 ports for callers. DATES: The meeting will be held on February 13, 2019, 10:30 a.m. to 3:30 p.m. EST. ADDRESSES: Audio Conference Call via FTS Conferencing. The USA toll-free dial-in number is 1–866–659–0537; the pass code is 9933701. FOR FURTHER INFORMATION CONTACT: Theodore Katz, MPA, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E–20, Atlanta, Georgia 30329, Telephone (513) 533– 6800, Toll Free 1 (800) CDC–INFO, Email ocas@cdc.gov. SUPPLEMENTARY INFORMATION: Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines that have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction, which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation amozie on DSK3GDR082PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 16:01 Jan 25, 2019 Jkt 247001 and reconstruction efforts being performed for purposes of the compensation program; and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, rechartered on February 12, 2018, pursuant to Executive Order 13708, and will terminate on March 22, 2020. Purpose: The Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advise the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. SPR is responsible for overseeing, tracking, and participating in the reviews of all procedures used in the dose reconstruction process by the NIOSH Division of Compensation Analysis and Support (DCAS) and its dose reconstruction contractor (Oak Ridge Associated Universities—ORAU). Matters to be Considered: The agenda will include discussions on the following dose reconstruction procedures: (a) Procedures associated specifically with the following sites: Aliquippa Forge, Hooker Electrochemical Co., Birdsboro Steel, Simonds Saw, Idaho National Laboratory, General Steel Industries; (b) general procedures for dose reconstructions: Internal Coworker Dosimetry Data Completeness Test, Parameters when Processing Claims for Construction Trade Workers. Agenda items are subject to change as priorities dictate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and PO 00000 Frm 00016 Fmt 4703 Sfmt 4703 Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–00195 Filed 1–25–19; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting of the Advisory Board on Radiation and Worker Health (ABRWH). This meeting is open to the public, but without a public comment period. The public is welcome to submit written comments in advance of the meeting, to the contact person below. Written comments received in advance of the meeting will be included in the official record of the meeting. The public is also welcome to listen to the meeting by joining the audio conference (information below). The audio conference line has 150 ports for callers. DATES: The meeting will be held on February 27, 2019, 11:00 a.m. to 1:00 p.m. EST. ADDRESSES: Audio Conference Call via FTS Conferencing. The USA toll-free dial-in number is 1–866–659–0537; the passcode is 9933701. FOR FURTHER INFORMATION CONTACT: Theodore Katz, MPA, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road NE, Mailstop E–20, Atlanta, Georgia 30329, Telephone (513) 533–6800, Toll Free 1 (800) CDC–INFO, Email ocas@cdc.gov. SUPPLEMENTARY INFORMATION: Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of SUMMARY: E:\FR\FM\28JAN1.SGM 28JAN1 amozie on DSK3GDR082PROD with NOTICES1 Federal Register / Vol. 84, No. 18 / Monday, January 28, 2019 / Notices probability of causation guidelines which have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, rechartered under Executive Order 13811 on February 12, 2018, and will terminate on March 22, 2020. Purpose: This Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters to be Considered: The agenda will include discussions on: Recording December 2018 Meeting Absentee Votes; Work Group and Subcommittee Reports; Update on the Status of SEC Petitions; Plans for the April 2019 Advisory Board Meeting; and Advisory Board Correspondence. Agenda items are subject to change as priorities dictate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–00196 Filed 1–25–19; 8:45 am] BILLING CODE 4163–19–P VerDate Sep<11>2014 16:01 Jan 25, 2019 Jkt 247001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), announces the following meeting of the Advisory Committee on Immunization Practices (ACIP). This meeting is open to the public, limited only by room seating. The meeting room accommodates 216 for public seating. Rooms 245, 246, and 247, adjacent to the meeting room, will be available once the meeting room reaches capacity, providing up to 120 additional seats. Time will be available for public comment. The meeting will be webcast live via the World Wide Web; for instructions and more information on ACIP please visit the ACIP website: https://www.cdc.gov/ vaccines/acip/. DATES: The meeting will be held on February 27, 2019, 8:00 a.m. to 5:30 p.m., EST, and February 28, 2019, 8:30 a.m. to 3:30 p.m. EST. ADDRESSES: CDC, 1600 Clifton Road, NE, Tom Harkin Global Communications Center, Building 19, Kent ‘Oz’ Nelson Auditorium, Atlanta, Georgia 30329–4027. FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee Management Specialist, CDC, NCIRD, telephone 404–639–8836, email ACIP@ cdc.gov. SUMMARY: SUPPLEMENTARY INFORMATION: Purpose: The committee is charged with advising the Director, CDC, on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding dosing interval, dosage, and contraindications to administration of vaccines. Further, under provisions of the Affordable Care Act, section 2713 of the Public Health Service Act, immunization recommendations of the ACIP that have been approved by the Director of the Centers for Disease Control and Prevention and appear on CDC PO 00000 Frm 00017 Fmt 4703 Sfmt 4703 427 immunization schedules must be covered by applicable health plans. Public Comment Oral Public Comment: This meeting will include one 75-minute session for oral public comment during which members of the public may make an inperson public comment. The oral public comment session will occur near the end of the first day’s session on February 27, 2019 and before any scheduled votes including all votes relevant to the ACIP’s Affordable Care Act and Vaccines for Children Program roles. Priority will be given to individuals who submit a request to make an oral public comment before the meeting according to the procedures below. On-site, in-person registration for oral public comment at the meeting will only be available if there is time remaining in the oral public comment session after all individuals who submitted a request to make an oral comment before the meeting have had an opportunity to speak. There is no guarantee there will be an opportunity for on-site, in-person registration for oral public comment, and all individuals interested in requesting to make an oral public comment are strongly encouraged to submit a request according to the instructions below. Procedure for Oral Public Comment: All persons interested in making an oral public comment at the February ACIP meeting must submit a request at https:// www.cdc.gov/vaccines/acip/meetings/ no later than 11:59 p.m., EDT, February 13, 2019. Interested persons must include their name; the name of the group or organization the individual is representing, if applicable; and contact information, including email address, mailing address, and telephone number. If the number of persons requesting to speak is greater than can be reasonably accommodated during the scheduled 75-minute oral public comment session, CDC will conduct a lottery to determine the speakers for the scheduled session. CDC staff will notify individuals regarding their request to speak by email by February 15, 2019. To accommodate the significant interest in participation in the oral public comment session of ACIP meetings, each speaker will be limited to 3 minutes, and each speaker may only speak once per meeting. Interested persons who are unable to make an oral public comment during this meeting are invited to submit a written comment according to the instructions below. Written Public Comment: Written comments will be accepted up to 48 hours following the end of the ACIP Meeting. You may submit comments, E:\FR\FM\28JAN1.SGM 28JAN1

Agencies

[Federal Register Volume 84, Number 18 (Monday, January 28, 2019)]
[Notices]
[Pages 426-427]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00196]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Board on Radiation and Worker Health (ABRWH or the 
Advisory Board), National Institute for Occupational Safety and Health 
(NIOSH)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting of the Advisory Board on Radiation and 
Worker Health (ABRWH). This meeting is open to the public, but without 
a public comment period. The public is welcome to submit written 
comments in advance of the meeting, to the contact person below. 
Written comments received in advance of the meeting will be included in 
the official record of the meeting. The public is also welcome to 
listen to the meeting by joining the audio conference (information 
below). The audio conference line has 150 ports for callers.

DATES: The meeting will be held on February 27, 2019, 11:00 a.m. to 
1:00 p.m. EST.

ADDRESSES: Audio Conference Call via FTS Conferencing. The USA toll-
free dial-in number is 1-866-659-0537; the passcode is 9933701.

FOR FURTHER INFORMATION CONTACT: Theodore Katz, MPA, Designated Federal 
Officer, NIOSH, CDC, 1600 Clifton Road NE, Mailstop E-20, Atlanta, 
Georgia 30329, Telephone (513) 533-6800, Toll Free 1 (800) CDC-INFO, 
Email ocas@cdc.gov.

SUPPLEMENTARY INFORMATION: 
    Background: The Advisory Board was established under the Energy 
Employees Occupational Illness Compensation Program Act of 2000 to 
advise the President on a variety of policy and technical functions 
required to implement and effectively manage the new compensation 
program. Key functions of the Advisory Board include providing advice 
on the development of

[[Page 427]]

probability of causation guidelines which have been promulgated by the 
Department of Health and Human Services (HHS) as a final rule, advice 
on methods of dose reconstruction which have also been promulgated by 
HHS as a final rule, advice on the scientific validity and quality of 
dose estimation and reconstruction efforts being performed for purposes 
of the compensation program, and advice on petitions to add classes of 
workers to the Special Exposure Cohort (SEC). In December 2000, the 
President delegated responsibility for funding, staffing, and operating 
the Advisory Board to HHS, which subsequently delegated this authority 
to the CDC. NIOSH implements this responsibility for CDC. The charter 
was issued on August 3, 2001, renewed at appropriate intervals, 
rechartered under Executive Order 13811 on February 12, 2018, and will 
terminate on March 22, 2020.
    Purpose: This Advisory Board is charged with (a) providing advice 
to the Secretary, HHS, on the development of guidelines under Executive 
Order 13179; (b) providing advice to the Secretary, HHS, on the 
scientific validity and quality of dose reconstruction efforts 
performed for this program; and (c) upon request by the Secretary, HHS, 
advising the Secretary on whether there is a class of employees at any 
Department of Energy facility who were exposed to radiation but for 
whom it is not feasible to estimate their radiation dose, and on 
whether there is reasonable likelihood that such radiation doses may 
have endangered the health of members of this class.
    Matters to be Considered: The agenda will include discussions on: 
Recording December 2018 Meeting Absentee Votes; Work Group and 
Subcommittee Reports; Update on the Status of SEC Petitions; Plans for 
the April 2019 Advisory Board Meeting; and Advisory Board 
Correspondence. Agenda items are subject to change as priorities 
dictate.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-00196 Filed 1-25-19; 8:45 am]
 BILLING CODE 4163-19-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.